Controversies in treatment of chronic obstructive pulmonary diseaseRABE, Klaus F; WEDZICHA, Jadwiga A.Lancet (British edition). 2011, Vol 378, Num 9795, pp 1038-1047, issn 0140-6736, 10 p.Article

Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseRABE, Klaus F.British journal of pharmacology. 2011, Vol 163, Num 1, pp 53-67, issn 0007-1188, 15 p.Article

Role of defensins in inflammatory lung diseaseAARBIOU, Jamil; RABE, Klaus F; HIEMSTRA, Pieter S et al.Annals of medicine (Helsinki). 2002, Vol 34, Num 2, pp 96-101, issn 0785-3890Article

Phosphodiesterase-4 Inhibitor Therapy for Lung DiseasesBEGHE, Bianca; RABE, Klaus F; FABBRI, Leonardo M et al.American journal of respiratory and critical care medicine. 2013, Vol 188, Num 3, pp 271-278, issn 1073-449X, 8 p.Article

TGF-β differentially regulates T_H2 cytokine-induced eotaxin and eotaxin-3 release by human airway smooth muscle cellsZUYDERDUYN, Suzanne; HIEMSTRA, Pieter S; RABE, Klaus F et al.Journal of allergy and clinical immunology. 2004, Vol 114, Num 4, pp 791-798, issn 0091-6749, 8 p.Article

Systemic Manifestations of COPDNUSSBAUMER-OCHSNER, Yvonne; RABE, Klaus F.Chest (American College of Chest Physicians). 2011, Vol 139, Num 1, pp 165-173, issn 0012-3692, 9 p.Article

Burden and clinical features of chronic obstructive pulmonary disease (COPD)PAUWELS, Romain A; RABE, Klaus F.Lancet (British edition). 2004, Vol 364, Num 9434, pp 613-620, issn 0140-6736, 8 p.Article

Eus-guided FNA of centrally located lung tumours following a non-diagnostic bronchoscopyANNEMA, Jouke T; VESELIC, Maud; RABE, Klaus F et al.Lung cancer. 2005, Vol 48, Num 3, pp 357-361, issn 0169-5002, 5 p.Article

A refugee with a supraclavicular lymph node : An uncommon first presentation of carcinoma of the prostateBOSSINK, Ailko W. J; RABE, Klaus F.Netherlands journal of medicine. 2001, Vol 58, Num 1, pp 22-26, issn 0300-2977Article

Update in chronic obstructive pulmonary disease 2005FABBRI, Leonardo M; LUPPI, Fabrizio; BEGHE, Bianca et al.American journal of respiratory and critical care medicine. 2006, Vol 173, Num 10, pp 1056-1065, issn 1073-449X, 10 p.Article

Transaortic EUS-guided FNA in the diagnosis of lung tumors and lymph nodesVON BARTHELD, Martin B; RABE, Klaus F; ANNEMA, Jouke T et al.Gastrointestinal endoscopy (Print). 2009, Vol 69, Num 2, pp 345-349, issn 0016-5107, 5 p.Article

Predictors of poor Asthma control in European adultsSORIANO, Joan B; RABE, Klaus F; VERMEIRE, Paul A et al.The Journal of asthma. 2003, Vol 40, Num 7, pp 803-813, issn 0277-0903, 11 p.Article

Update in chronic obstructive pulmonary disease 2006RABE, Klaus F; BEGHE, Bianca; LUPPI, Fabrizio et al.American journal of respiratory and critical care medicine. 2007, Vol 175, Num 12, pp 1222-1232, issn 1073-449X, 11 p.Article

Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD. CommentaryCAZZOLA, Mario; MATERA, Maria Gabriella; RABE, Klaus F et al.Chest. 2008, Vol 134, Num 2, issn 0012-3692, 223-225, 255-262 [11 p.]Article

Novel concepts of neuropeptide-based drug therapy : Vasoactive intestinal polypeptide and its receptorsGRONEBERG, David A; RABE, Klaus F; FISCHER, Axel et al.European journal of pharmacology. 2006, Vol 533, Num 1-3, pp 182-194, issn 0014-2999, 13 p.Article

An official American Thoracic Society and European Respiratory Society policy statement: disparities in respiratory healthSCHRAUFNAGEL, Dean E; BLASI, Francesco; KRAFT, Monica et al.The European respiratory journal. 2013, Vol 42, Num 4, pp 906-915, issn 0903-1936, 10 p.Article

Management of non-small-cell lung cancer: recent developmentsRECK, Martin; HEIGENER, David F; MOK, Tony et al.Lancet (British edition). 2013, Vol 382, Num 9893, pp 709-719, issn 0140-6736, 11 p.Article

The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cellsZUYDERDUYN, Suzanne; NINABER, Dennis K; HIEMSTRA, Pieter S et al.Journal of allergy and clinical immunology. 2006, Vol 117, Num 6, pp 1328-1335, issn 0091-6749, 8 p.Article

Exploring host-pathogen interactions at the epithelial surface : application of transcriptomics in lung biologyVOS, Joost B; DATSON, Nicole A; RABE, Klaus F et al.American journal of physiology. Lung cellular and molecular physiology. 2007, Vol 36, Num 2, issn 1040-0605, L367-L377Article

Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical stagingANNEMA, Jouke T; VERSTEEGH, Michel I; VESELIC, Maud et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8357-8361, issn 0732-183X, 5 p.Article

Assessment of microvascular leakage via sputum induction: The role of substance P and neurokinin A in patients with asthmaVAN RENSEN, Elizabeth L. J; HIEMSTRA, Pieter S; RABE, Klaus F et al.American journal of respiratory and critical care medicine. 2002, Vol 165, Num 9, pp 1275-1279, issn 1073-449XArticle

The EvA study: aims and strategyZIEGLER-HEITBROCK, Loems; FRANKENBERGER, Marion; SINGH, Dave et al.The European respiratory journal. 2012, Vol 40, Num 4, pp 823-829, issn 0903-1936, 7 p.Article

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsCALVERLEY, Peter M. A; RABE, Klaus F; GOEHRING, Udo-Michael et al.Lancet (British edition). 2009, Vol 374, Num 9691, pp 685-694, issn 0140-6736, 10 p.Article

Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptorsTJABRINGA, G. Sandra; NINABER, Dennis K; DRIJFHOUT, Jan Wouter et al.International archives of allergy and immunology. 2006, Vol 140, Num 2, pp 103-112, issn 1018-2438, 10 p.Article

A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPDOHTA, Ken; FUKUCHI, Yoshinosuke; GROUSE, Lawrence et al.Respiratory medicine. 2004, Vol 98, Num 10, pp 1016-1024, issn 0954-6111, 9 p.Article